Novavax, Inc. (NASDAQ:NVAX – Free Report) – Research analysts at Zacks Research upped their Q2 2025 earnings per share (EPS) estimates for shares of Novavax in a note issued to investors on ...

The most recent trading session ended with Novavax (NVAX) standing at $9.34, reflecting a +1.3% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily loss of 1.46%.

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...

Novavax (NVAX) has been one of the most searched-for ... we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock ...

The average of price targets set by Wall Street analysts indicates a potential upside of 81.6% in Novavax (NVAX). While the effectiveness of this highly sought-after metric is questionable, the ...

Novavax (NVAX) has been one of the most searched-for stocks on ... Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is ...

Bullish option flow detected in Novavax (NVAX) with 5,702 calls trading, 1.1x expected, and implied vol increasing almost 10 points to 99.21%.

If you are looking for an AI stock that is more promising than NVAX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched ... Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection.